Polyclonal Rabbit anti‑Mouse CACNA1H / Cav3.2 Antibody (PE, aa2160‑2359, WB) LS‑C727367
Polyclonal Rabbit anti‑Mouse CACNA1H / Cav3.2 Antibody (PE, aa2160‑2359, WB) LS‑C727367
Antibody:
CACNA1H / Cav3.2 Rabbit anti-Mouse Polyclonal (aa2160-2359) (PE) Antibody
Format:
Phycoerythrin, Unmodified
Overview
Antibody:
CACNA1H / Cav3.2 Rabbit anti-Mouse Polyclonal (aa2160-2359) (PE) Antibody
Format:
Phycoerythrin, Unmodified
Specifications
Description
Cav3.2 antibody LS-C727367 is a PE-conjugated rabbit polyclonal antibody to mouse Cav3.2 (CACNA1H) (aa2160-2359). Validated for WB.
Target
Mouse CACNA1H / Cav3.2
Synonyms
CACNA1H | Alpha 1h | Cav3.2 | CACNA1HB | EIG6 | MNCb-1209 | ECA6
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Phycoerythrin.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
Cy3,
HRP,
APC,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant CACNa1H (Ser2160-Val2359)
Specificity
The antibody is a rabbit polyclonal antibody raised against CACNa1H.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
IHC, Western blot, ELISA
Species:
Human, Mouse, Rat
Applications:
IHC, ICC, Immunofluorescence, Western blot
Species:
Human, Mouse
Applications:
IHC, ICC, Immunofluorescence, Western blot
Species:
Human, Mouse, Rat
Applications:
Western blot
Reactivity:
Human
Range:
0.312-20 ng/ml
Reactivity:
Human
Range:
0.156-10 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 3/28/2024